Literature DB >> 30225607

A pilot study assessing T1-weighted muscle MRI in amyotrophic lateral sclerosis (ALS).

Luca Diamanti1,2, Enrico Alfonsi3, Ottavia Eleonora Ferraro4, Cristina Cereda5, Orietta Pansarasa5, Stefano Bastianello6,7, Anna Pichiecchio7.   

Abstract

The authors set out to study the role of T1-weighted muscle MRI in the diagnostic phase of ALS, comparing images from ten patients and nine age-matched healthy controls (HCs). All subjects underwent MRI of 68 muscles in the hands, paraspinal regions and lower limbs; the images were semi-quantitatively scored. Atrophy was more frequent in muscles of ALS patients than HCs (p < 0.0001); fatty infiltration was particularly marked in iliopsoas (p = 0.046), anterior (p = 0.020) and posterior (p = 0.047) calf muscles in patients. A trend towards agreement was found between MRI and clinic-EMG data for the first dorsal interosseous, paraspinal, and tibial anterior muscles. Muscle T1-weighted MRI can distinguish ALS patients from HCs for specific regions (i.e., legs). MRI abnormalities could be found in pauci-symptomatic spinal muscles in bulbar-onset patients. Muscle MRI may be a useful diagnostic tool in ALS, in particular for muscles difficult to investigate using clinical-EMG methods.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Biomarkers; Electromyography; Muscle damage; Muscle magnetic resonance imaging

Mesh:

Year:  2018        PMID: 30225607     DOI: 10.1007/s00256-018-3073-7

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  6 in total

1.  Carboxyl-terminal modulator protein regulates Akt signaling during skeletal muscle atrophy in vitro and a mouse model of amyotrophic lateral sclerosis.

Authors:  Junmei Wang; Colin M E Fry; Chandler L Walker
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

2.  Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity.

Authors:  Uros Klickovic; Luca Zampedri; Christopher D J Sinclair; Stephen J Wastling; Karin Trimmel; Robin S Howard; Andrea Malaspina; Nikhil Sharma; Katie Sidle; Ahmed Emira; Sachit Shah; Tarek A Yousry; Michael G Hanna; Linda Greensmith; Jasper M Morrow; John S Thornton; Pietro Fratta
Journal:  Neurology       Date:  2019-08-07       Impact factor: 9.910

3.  Characterization of AAV-mediated dorsal root ganglionopathy.

Authors:  Nicholas Buss; Lisa Lanigan; Jillynne Zeller; Derek Cissell; Monica Metea; Eric Adams; Mikayla Higgins; Kwi Hye Kim; Ewa Budzynski; Lin Yang; Ye Liu; Mark Butt; Olivier Danos; Michele Fiscella
Journal:  Mol Ther Methods Clin Dev       Date:  2022-02-01       Impact factor: 6.698

4.  Longitudinal Quantitative MRI Evaluation of Muscle Involvement in Amyotrophic Lateral Sclerosis.

Authors:  Matteo Paoletti; Luca Diamanti; Shaun I Muzic; Elena Ballante; Francesca Solazzo; Lia Foppoli; Xeni Deligianni; Francesco Santini; Silvia Figini; Niels Bergsland; Anna Pichiecchio
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

5.  MRI study of paraspinal muscles in patients with Amyotrophic Lateral Sclerosis (ALS).

Authors:  Luca Diamanti; Matteo Paoletti; Umberto Di Vita; Shaun Ivan Muzic; Cristina Cereda; Elena Ballante; Anna Pichiecchio
Journal:  J Clin Med       Date:  2020-03-28       Impact factor: 4.241

6.  Longitudinal multi-modal muscle-based biomarker assessment in motor neuron disease.

Authors:  Thomas M Jenkins; James J P Alix; Jacob Fingret; Taniya Esmail; Nigel Hoggard; Kathleen Baster; Christopher J McDermott; Iain D Wilkinson; Pamela J Shaw
Journal:  J Neurol       Date:  2019-10-17       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.